Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03189446 · ClinicalTrials.gov registry record · Phase 2
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer
A Phase 2 study, sponsored by University of Oklahoma.
- Completed
- Registry status
- Phase 2
- Development phase
- 39
- Enrollment target
NCT03189446 is a Phase 2 study that has completed, run by University of Oklahoma. The registered enrollment target is 39 participants.
The verdict
NCT03189446, a Phase 2 study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of treatment in patients with high risk endometrial cancer treated by vaginal cuff brachytherapy followed by 3 cycles of dose dense paclitaxel and carboplatin chemotherapy.
Interventions
- DRUG Carboplatin
- DRUG Paclitaxel
- RADIATION Vaginal Cuff Brachytherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2017-10-02 |
| Est. Completion | 2021-10-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03189446
The ClinicalTrials.gov registry entry for NCT03189446 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Carboplatin is the first listed.
NCT03189446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03189446 about?
NCT03189446 is a clinical study titled "Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer". The purpose of this study is to determine the feasibility of treatment in patients with high risk endometrial cancer treated by vaginal cuff brachytherapy followed by 3 cycles of dose dense paclitaxel and carboplatin chemotherapy.
What is the current status of trial NCT03189446?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 39 participants. The study started on 2017-10-02. Estimated completion is 2021-10-06.
What interventions are being tested in trial NCT03189446?
The interventions under investigation include: Carboplatin (DRUG), Paclitaxel (DRUG), Vaginal Cuff Brachytherapy (RADIATION).
Who is sponsoring clinical trial NCT03189446?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.